share_log

Raymond James Initiates Coverage On Fulgent Genetics With Outperform Rating, Announces Price Target of $45

Raymond James Initiates Coverage On Fulgent Genetics With Outperform Rating, Announces Price Target of $45

雷蒙德·詹姆斯以優於大盤的評級啟動對富金特遺傳的報道,宣佈目標價為45美元
Benzinga Real-time News ·  2022/11/18 07:31

Raymond James analyst Andrew Cooper initiates coverage on Fulgent Genetics (NASDAQ:FLGT) with a Outperform rating and announces Price Target of $45.

Raymond James分析師安德魯·庫珀對Fulgent Genetics(納斯達克:FLGT)發起報道,評級優於大盤,並宣佈目標價為45美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論